BioregulatorResearch
Thymogen
Also known as: Glu-Trp · EW dipeptide
A synthetic dipeptide with intense thymopoietic activity, used to reconstruct destroyed immune systems post-radiation or immunosuppression.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
Half-Life
~20–30 minutes
Typical Dose
100 mcg intranasal or SC
Administration
Intranasal or subcutaneous
Mechanism of Action
Activates thymic function through minimal dipeptide signaling, stimulating T-cell differentiation and maturation.
Key Research Areas
bioregulatorimmunethymusdipeptide
Frequently Asked Questions
What is Thymogen?▾
A synthetic dipeptide with intense thymopoietic activity, used to reconstruct destroyed immune systems post-radiation or immunosuppression.
How does Thymogen work?▾
Activates thymic function through minimal dipeptide signaling, stimulating T-cell differentiation and maturation.
What is the recommended dosage for Thymogen?▾
The typical research dosage is 100 mcg intranasal or SC, administered via Intranasal or subcutaneous. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Thymogen?▾
The half-life of Thymogen is approximately ~20–30 minutes. This affects dosing frequency and timing in research protocols.
Is Thymogen FDA approved?▾
Thymogen is currently classified as "Research" and is not FDA approved for general use. It is available for research purposes or through compounding pharmacies depending on your jurisdiction.
Research Disclaimer
The information provided about Thymogen is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.